Landscapes / Companies
Adlai Nortye Biopharma Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 1
Drugs
4
in active trials · 8 in all
Trials
4 active
10 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Nov 2026soonPhase 1 trial completes | |||
| Next date | Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Lymphoma | ||||
| Open drug page | |||||
— |
Phase 1 | Jul 2027Phase 1 trial completes | |||
| Next date | Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor (Phase 1) | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Jan 2028Phase 1 trial completes | |||
| Next date | 31 Jan 2028 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors (Phase 1), RAS Mutation | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2028Phase 1 trial completes | |||
| Next date | 31 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor (Phase I), RAS Mutation and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- AN0025, AN2025, Buparlisib & Paclitaxel, folinic acid/5-FU/oxaliplatin
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021